The Prevent Cancer Foundation is accepting applications for its 2025 Research Grants and Fellowships Program, which funds innovative cancer prevention and early detection research. As the only U.S.-based nonprofit solely dedicated to this mission, the Foundation supports a range of research at leading and emerging academic institutions and cancer centers across the United States.
Applications are welcome from projects that align with one of four tracks: translational research, implementation/dissemination science, population health, and clinical trials. Researchers must also select up to four focus areas such as epidemiology, biomarkers, behavioral intervention, or immunoprevention. Eligible research must have the potential for significant near-term impact, particularly if translatable into clinical or community settings within five years.
Each grant is valued at $100,000 over two years ($50,000/year). Funds must be used specifically for the approved project, excluding indirect costs. Grant applications are peer-reviewed and evaluated for significance, innovation, methodology, and alignment with cancer prevention goals. Applications involving tobacco industry-funded researchers or institutions are strictly prohibited.
The application portal opened on May 27, 2025, and the deadline is July 15, 2025 at 11:59 p.m. ET. Notifications will be issued by December 5, 2025, and projects must begin by January 15, 2026. Required documentation includes a signed tobacco compliance statement, IRB/IACUC approvals (if applicable), biosketches, a full research plan, and institutional nonprofit verification.
Applications must be submitted via ProposalCentral. For technical support, applicants can contact ProposalCentral support, and for grant-related inquiries, contact Ximena Marquez Dagan at Ximena.Marquez@preventcancer.org. Full award details and guidelines are outlined in the grant instructions and FAQs available on the Foundation’s website.
Submit via ProposalCentral; include tobacco policy compliance, institutional documents, complete biosketches and plans.
